At Maha Pharma, we take our research and development responsibilities seriously. Since we opened our doors in 2002, our active research team has undertaken more than 35 clinical trials, enrolling nearly 4,000 patients.
Deca 300 by Maha Pharma works in a very unique way. The name of the active ingredient in it is a special type of anabolic steroid known as nandrolone Decanoate. In order to understand how Deca 300 operates, one has to first understand that anabolic steroids exhibit properties which are similar to those of the naturally-occurring hormone testosterone.
Is there a difference between drugs, or is one steroid the same as another? Can you get cut of D-Bol and add size with Winstrol? You bet!
Solution - 1 ml.
Active substance: Erythropoietin beta 2000 IU / 3000 IU or 4000 IU.
The solution is in the form of a colorless transparent liquid.
Stimulating hematopoiesis.
After sc administration of Eprex in plasma is achieved after 12-28 hours. T1 / 2 in the final phase is 13-28 hours. After iv administration of T1 / 2 the active substance is 4-12 hours.
Recombinant human erythropoietin (purified glycoprotein), which is a hematopoietic growth factor. Obtained by genetic engineering. Increases the number of red blood cells, reticulocytes, stimulates the synthesis of hemoglobin in the cells. It does not affect leukopoiesis. It is believed that erythropoietin interacts with specific erythropoietin receptors on the cell surface.
The stimulator of erythropoiesis.
Inject it subcutaneously and intravenously.
Uncontrolled hypertension, myocardial infarction or cerebral stroke during the previous month, unstable angina pectoris, history of thromboembolism, hypersensitivity to epoetin beta.
Used with caution in case of epilepsy, thrombocytosis, liver failure, vascular insufficiency, and malignant neoplasms; in patients with nephrosclerosis who are not receiving hemodialysis, since a more rapid deterioration of renal function is possible.
During pregnancy, only if the intended benefit to the mother significantly exceeds the potential risk to the fetus.
From the cardiovascular system: arterial hypertension, hypertensive crisis are possible.
From the side of the central nervous system: encephalopathy is possible (more often with hypertensive crises), headache, confusion.
From the blood coagulation system: rarely - thrombocytosis, thrombotic complications.
From the side of metabolism: rarely - hyperkalemia.
Allergic reactions: rarely - skin rash, anaphylactoid reactions.
With the simultaneous use of drugs that affect blood formation (for example, iron preparations), the stimulating effect of epoetin beta may increase.
Initial doses are 50-150 IU / kg, the frequency of administration is on average 3 times a week.
Maha Pharma is a strong advocate of customer privacy and as such we are committed to meeting or exceeding the privacy standards established by International's Personal Information Protection and Electronic Documents Act.
Services provided by: Maha Pharma Inc., Europe
Pharmacy licensed in Europe by the EU Pharmaceutical Association, License #32162
Copyright Maha Pharma 2002-